[PMID: 9656205] PubMed record related to this compound for laboratory literature review
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
An unregulated supply chain can result in the production of fraudulent products, medication containing incorrect ingredients, or products with either too high or too low potency, leading to inconsistent results and danger
Agarwal A, Durairajanayagam D, du Plessis SS
The headline result was a mean 17.5% body-weight reduction at 24 weeks in the 12 mg arm, with clear dose-response behavior across the four active doses
The NHS and NICE do not recommend peptides for ED, instead advocating proven treatments like PDE5 inhibitors (sildenafil, tadalafil)